Last updated: February 22, 2026
What is NDC 52817-0325?
The drug identified by NDC 52817-0325 is a specific pharmaceutical product, typically indicated for a particular treatment area. Based on available NDC listings, this drug corresponds to [product name, e.g., "Xyrem (Sodium oxybate)"], approved by the FDA for [specific indications].
Current Market Landscape
Market Size and Revenue
- The global market for [indication, e.g., narcolepsy treatment] was valued at approximately $X billion in 2022.
- The U.S. market accounts for Y% of this global value, roughly $Z billion.
- The drug's current sales in the U.S. stood at $A million in 2022, representing B% growth over the previous year.
Competitor Analysis
- Main competitors include [list of key drugs, e.g., "Xyrem, XYWAV, and SODROXA"].
- Market shares are distributed as follows: Xyrem (C%), XYWAV (D%), SODROXA (E%).
- Generic alternatives are limited due to patent protections and regulatory exclusivities.
Regulatory Status
- FDA approvals for [indication] granted on [date].
- Patent expiration is projected for [year], with exclusivity rights ending in [year].
- Recent legal disputes or patent challenges could influence market dynamics.
Access and Reimbursement
- Medicare and private insurance coverage for [indication] is widespread.
- Average copay ranges from $X to $Y.
- Price reimbursement policies directly impact patient access and market share.
Price Movements and Trends
Current Pricing
- The average wholesale price (AWP) for a typical 30-day supply is $X, with a range from $Y to $Z depending on dosage and supplier.
- Retail prices are approximately $A per unit/dose.
Historical Price Trends
- Over the past 3 years, the drug's price increased annually by X%.
- Price hikes correlate with supply chain constraints and increased manufacturing costs.
Future Price Projections (Next 1-3 Years)
| Year |
Estimated Wholesale Price (30-day supply) |
Basis of Estimate |
| 2023 |
$X |
Current price, inflation adjustments, supply stability |
| 2024 |
$Y |
Market demand, competitor pricing, regulatory landscape |
| 2025 |
$Z |
Patent expiry effects, generic entry, policy shifts |
Projections assume market stability, with potential declines post-patent expiration and increased biosimilar/generic competition. Price increases are expected if supply constraints persist, but regulatory pressures may contain growth.
Factors Influencing Market and Price
- Patent expiration is expected around [year], potentially introducing generics and reducing prices.
- Manufacturing costs increase, driven by raw material prices and quality standards.
- Regulatory policies, such as price caps or rebate structures, could limit price rise potential.
- Market adoption rate hinges on formulary inclusion and insurer reimbursement policies.
- Competitive entry of biosimilars/generics could lower average prices by [percentage].
Key Takeaways
- The drug holds a significant market share in its therapeutic niche, supported by FDA approval, limited competition, and established reimbursement.
- Pricing has been steadily increasing, influenced by supply constraints and regulatory environment.
- Patent expiries and emerging biosimilar entries are likely to exert downward pressure on prices within the next 2-3 years.
- Market dynamics remain sensitive to changes in regulatory policies, manufacturing costs, and competitive landscape shifts.
FAQs
1. What is the main driver of price increases for NDC 52817-0325?
Supply chain constraints, increased manufacturing costs, and high demand contribute to price hikes.
2. When is patent expiration expected for this drug?
Assuming typical patent life, expiration is projected around [year], unless delayed by legal or regulatory factors.
3. How do competitor products impact the market share of NDC 52817-0325?
New entrants, including biosimilars or generic versions, can erode market share and exert downward pressure on pricing.
4. What pricing strategies could prepare stakeholders for patent expiration?
Developing value-based pricing models and early adoption of biosimilars can mitigate revenue loss.
5. How might regulatory changes affect future pricing?
Price caps, reimbursement reforms, or increased transparency mandates could limit profit margins and influence pricing strategies.
References
[1] U.S. Food and Drug Administration. (2023). Drug Approvals and Labeling. [Data file].
[2] IQVIA. (2023). National Sales Perspective. Market analysis reports.
[3] Pharmacy Times. (2022). Pricing Trends in Specialty Drugs.
[4] FDA Orange Book. (2023). Patent and Exclusivity Data.
[5] CMS. (2023). Reimbursement Policies for Prescription Drugs.
